|
1
|
Han S, Zhang S and Chen W: Analysis of the
status and trends of bladder cancer incidence in China. Oncol
Progress. 11:89–95. 2013.
|
|
2
|
Ploeg M, Aben KK and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Babjuk M, Burger M, Zigeuner R, et al: EAU
guidelines on non-muscle-invasive urothelial carcinoma of the
bladder: update 2013. Eur Urol. 64:639–653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Enderling H, Hlatky L and Hahnfeldt P:
Cancer stem cells: a minor cancer subpopulation that redefines
global cancer features. Front Oncol. 3:762013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siddique HR and Saleem M: Role of BMI1, a
stem cell factor, in cancer recurrence and chemoresistance:
preclinical and clinical evidences. Stem Cells. 30:372–378. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugihara E and Saya H: Complexity of
cancer stem cells. Int J Cancer. 132:1249–1259. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kondo T: Stem cell-like cancer cells in
cancer cell lines. Cancer Biomark. 3:245–250. 2007.PubMed/NCBI
|
|
9
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar
|
|
10
|
Park IK, Morrison SJ and Clarke MF: Bmi1,
stem cells, and senescence regulation. J Clin Invest. 113:175–179.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jacobs JJ, Kieboom K, Marino S, DePinho RA
and van Lohuizen M: The oncogene and Polycomb-group gene bmi-1
regulates cell proliferation and senescence through the ink4a
locus. Nature. 397:164–168. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park IK, Qian D, Kiel M, et al: Bmi-1 is
required for maintenance of adult self-renewing haematopoietic stem
cells. Nature. 423:302–305. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siddique HR, Parray A, Tarapore RS, et al:
BMI1 polycomb group protein acts as a master switch for growth and
death of tumor cells: regulates TCF4-transcriptional factor-induced
BCL2 signaling. PLoS One. 8:e606642013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan X, Chen X, Deng W, Zhong G, Cai Q and
Lin T: Up-regulated microRNA-143 in cancer stem cells
differentiation promotes prostate cancer cells metastasis by
modulating FNDC3B expression. BMC Cancer. 13:612013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ponti D, Costa A, Zaffaroni N, et al:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang C, Ang BT and Pervaiz S: Cancer stem
cell: target for anti-cancer therapy. FASEB J. 21:3777–3785. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ning ZF, Huang YJ, Lin TX, et al:
Subpopulations of stem-like cells in side population cells from the
human bladder transitional cell cancer cell line T24. J Int Med
Res. 37:621–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Molofsky AV, He S, Bydon M, Morrison SJ
and Pardal R: Bmi-1 promotes neural stem cell self-renewal and
neural development but not mouse growth and survival by repressing
the p16Ink4a and p19Arf senescence pathways.
Genes Dev. 19:1432–1437. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cetin I and Topcul M: Cancer stem cells in
oncology. J BUON. 17:644–648. 2012.PubMed/NCBI
|
|
20
|
Moserle L, Ghisi M, Amadori A and
Indraccolo S: Side population and cancer stem cells: therapeutic
implications. Cancer Lett. 288:1–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oates JE, Grey BR, Addla SK, et al:
Hoechst 33342 side population identification is a conserved and
unified mechanism in urological cancers. Stem Cells Dev.
18:1515–1522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou S, Schuetz JD, Bunting KD, et al: The
ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem
cells and is a molecular determinant of the side-population
phenotype. Nat Med. 7:1028–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hepburn AC, Veeratterapillay R, Williamson
SC, et al: Side population in human non-muscle invasive bladder
cancer enriches for cancer stem cells that are maintained by MAPK
signalling. PLoS One. 7:e506902012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stingl J, Eirew P, Ricketson I, et al:
Purification and unique properties of mammary epithelial stem
cells. Nature. 439:993–997. 2006.PubMed/NCBI
|
|
26
|
Mitsutake N, Iwao A, Nagai K, et al:
Characterization of side population in thyroid cancer cell lines:
cancer stem-like cells are enriched partly but not exclusively.
Endocrinology. 148:1797–1803. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Triel C, Vestergaard ME, Bolund L, Jensen
TG and Jensen UB: Side population cells in human and mouse
epidermis lack stem cell characteristics. Exp Cell Res. 295:79–90.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Broadley KW, Hunn MK, Farrand KJ, et al:
Side population is not necessary or sufficient for a cancer stem
cell phenotype in glioblastoma multiforme. Stem Cells. 29:452–461.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lessard J and Sauvageau G: Bmi-1
determines the proliferative capacity of normal and leukaemic stem
cells. Nature. 423:255–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chiba T, Miyagi S, Saraya A, et al: The
polycomb gene product BMI1 contributes to the maintenance of
tumor-initiating side population cells in hepatocellular carcinoma.
Cancer Res. 68:7742–7749. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu S, Dontu G, Mantle ID, et al: Hedgehog
signaling and Bmi-1 regulate self-renewal of normal and malignant
human mammary stem cells. Cancer Res. 66:6063–6071. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Proctor E, Waghray M, Lee CJ, et al: Bmi1
enhances tumorigenicity and cancer stem cell function in pancreatic
adenocarcinoma. PLoS One. 8:e558202013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qin ZK, Yang JA, Ye YL, et al: Expression
of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer.
9:612009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liang W, Zhu D, Cui X, et al: Knockdown
BMI1 expression inhibits proliferation and invasion in human
bladder cancer T24 cells. Mol Cell Biochem. 382:283–291. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yin T, Wei H, Leng Z, et al: Bmi-1
promotes the chemoresistance, invasion and tumorigenesis of
pancreatic cancer cells. Chemotherapy. 57:488–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang E, Bhattacharyya S, Szabolcs A, et
al: Enhancing chemotherapy response with Bmi-1 silencing in ovarian
cancer. PLoS One. 6:e179182011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Falso MJ, Buchholz BA and White RW:
Stem-like cells in bladder cancer cell lines with differential
sensitivity to cisplatin. Anticancer Res. 32:733–738.
2012.PubMed/NCBI
|
|
38
|
Zhang Y, Wang Z, Yu J, et al: Cancer
stem-like cells contribute to cisplatin resistance and progression
in bladder cancer. Cancer Lett. 322:70–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Molofsky AV, Pardal R, Iwashita T, Park
IK, Clarke MF and Morrison SJ: Bmi-1 dependence distinguishes
neural stem cell self-renewal from progenitor proliferation.
Nature. 425:962–967. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Biehs B, Hu JK, Strauli NB, et al: BMI1
represses Ink4a/Arf and Hox genes to regulate stem cells in the
rodent incisor. Nat Cell Biol. 15:846–852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fasano CA, Dimos JT, Ivanova NB, Lowry N,
Lemischka IR and Temple S: shRNA knockdown of Bmi-1 reveals a
critical role for p21-Rb pathway in NSC self-renewal during
development. Cell Stem Cell. 1:87–99. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xu CR, Lee S, Ho C, et al: Bmi1 functions
as an oncogene independent of Ink4A/Arf repression in hepatic
carcinogenesis. Mol Cancer Res. 7:1937–1945. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Douglas D, Hsu JH, Hung L, et al: BMI-1
promotes Ewing sarcoma tumorigenicity independent of CDKN2A
repression. Cancer Res. 68:6507–6515. 2008. View Article : Google Scholar : PubMed/NCBI
|
